169325 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Nucleoproteins
P53 biomarkers
#302Biomarkers for predicting response to immunosuppressive therapy
#303HDAC REGULATION ASSAYS, COMPOUNDS AND THERAPEUTIC COMPOSITIONS
#304METHOD FOR THE DETECTION OF APOPTOSIS
#305Engineering enzymes through genetic selection
#306CENTROSOME AMPLIFICATION AS A BIOSENSOR FOR DNA DAMAGE
#307RAPID ASSAY FOR DETECTING ATAXIA-TELANGIECTASIA HOMOZYGOTES AND HETEROZYGOTES
#308PAX2 AND PAX8 AS TUMOUR TARGETS FOR IMMUNOLOGIC AND MOLECULAR TREATMENT STRATEGIES
#309HISTONE H2AX (HH2AX) BIOMARKER FOR FTI SENSITIVITY
#310Real-time analytical methods and systems
#311HNF4alpha MODULATORS AND METHODS OF USE
#312Conditionally Active Ribozymes And Uses Thereof
#313Lunasin-induced regulation of disease-related gene expression
#314HNF4alpha ANTAGONISTS AND METHODS OF USE
#315FLUORESCENT TWO-HYBRID (F2H) ASSAY FOR DIRECT VISUALIZATION OF PROTEIN INTERACTIONS IN LIVING CELLS
#316ADIPONECTIN EXPRESSION-INDUCING AGENTS AND USES THEREOF
#317Regeneration and neogenesis of retinal photoreceptor cell using Otx2 gene
#318Genotoxicity as a biomarker for inflammation
#319Use of an endogenous ligand for peroxisome proliferator activated receptor alpha to treat liver disorders
#320Anti aging agents and methods to identify them
#321Benzimidazole derivatives: preparation and pharmaceutical applications
#322MARKERS FOR DIAGNOSIS OF CANCER AND ITS USE
#323METHODS FOR MEASURING CELL RESPONSE TO DNA DAMAGING AGENTS USING PROMYELOCYTIC LEUKEMIA PROTEIN NUCLEAR BODIES
#324METHODS AND COMPOSITIONS FOR IDENTIFYING ANTI-HCV AGENTS
#325Substrate for Rpn 11 enzymatic activity
#326Method for screening compounds to determine those which enhance islet cell activity and/or survival and uses therefor
#327Lateral Flow Methods and Devices for Detection of Nucleic Acid Binding Proteins
#328Methods and compositions related to chromatin-associated proteins and other factors
#329Process for removing phosphorous from a fiber or yarn
#330HMG1 antibody for treating inflammatory conditions
#331Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
#332Methods for Identifying Modulators of Pyrimidine Tract Binding Protein
#333Regulation of protein synthesis
#334METHOD AND MEANS FOR DETECTING AND/OR QUANTIFYING HIERARCHICAL MOLECULAR CHANGE OF A CELL IN RESPONSE TO AN EXTERNAL STIMULUS
#335Modulation of NR2F6 and methods and uses thereof
#336METHODS INVOLVING LEF-1 REGULATION AND USE OF LEF-1 OR COMPOUNDS ALTERING LEF-1 SIGNALLING FOR TREATING OR PREVENTING DISEASES
#337Molecular Targets for Treatment of Learning and Memory Dysfunction
#338RIP140 regulation of diabetes
#339Agents for reversing epigenetic silencing of genes
#340Injection moulding method
#341Molecular accessibility assay
#342Methods for Identifying FZD8 Modulators and the Use of such Modulators for Treating Osteoarthritis
#343Nucleic acids encoding class II human histone deacetylases, and uses related thereto
#344Assays for Histone Deacetylase 1/2 Selective Inhibitors
#345Rhesus monkey Nur77
#346Antagonists of HMG1 for treating inflammatory conditions
#347METHODS FOR IDENTIFYING NUCLEAR RECEPTOR/LIGAND COMBINATIONS FOR TARGETING BRAIN TUMOR STEM CELLS AND FOR THEIR USE
#348Prognosis and treatment of breast cancer
#349TARGET MOLECULES OF PLADIENOLIDES, COMPOUNDS BINDING TO SUCH TARGET MOLECULES, AND SCREENING METHOD THEREOF
#350METHODS AND PRODUCTS TO TARGET, CAPTURE AND CHARACTERIZE STEM CELLS
#351INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE
#352Enhancing stem cell mobilization
#353Methods of detecting a plurality of sequence specific DNA binding proteins with oligonucleotide detection duplexes
#354PROTEIN DEMETHYLASES COMPRISING A JMJC DOMAIN
#355EPIGENETIC ANALYSES
#356Mutant proteins in the dna-binding domain of a telomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna
#357Methods to identify inhibitors of Runx1-mediated expression of nociceptive receptors and ion channels
#358Inhibition of GASC1
#359HISTONES
#360METHODS AND COMPOSITIONS FOR THE DETECTION OF CERVICAL DISEASE
#361METHODS OF TREATING AND DIAGNOSING LAMINOPATHY
#362Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#363DETECTION OF MEMBRANE ANDROGEN RECEPTOR (mAR) AGENTS
#364LXR ligand testing method
#365Alzheimer's related proteins and methods of use
#366Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents
#367Plus end-directed microtubule motor required for chromosome congression
#368METHODS AND COMPOSITIONS FOR THE DETECTION OF CERVICAL DISEASE
#369csPCNA isoform modifications and uses thereof
#370Compositions and methods for inhibiting car gene expression by RNA interference
#371Class II Human Histone Deacteylases, and Uses Related Thereto
#372Sigma-2 Receptor, Method of Screening of Specific Ligands and Use of the Same in Diagnostic or Therapeutic Methods
#373Use of LXR agonists for the treatment of osteoarthritis
#374Method for Localization of Nucleic Acid Associated Molecules and Modifications
#375Detection and diagnosis of inflammatory disorders
#376Process for the determination of inflammatory processes and pharmaceutical compositions for the treatment thereof
#377T-bet compositions and methods of use thereof
#378Modified human four helical bundle polypeptides and their uses
#379Compositions and Methods for Treating Mood and Anxiety Disorders
#380Method of Monitoring Anti-Tumor Activity of an Hdac Inhibitor
#381Antibodies Against Histone Modifications for Clinical Diagnosis and Prognosis of Cancer
#382Position dependent recognition of GNN nucleotide triplets by zinc fingers
#383SPHKS as modifiers of the p53 pathway and methods of use
#384MUC1-IκB kinase complexes and their activities
#385Modulation of Wrn-Mediated Telomere-Initiated Cell Signaling
#386p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR
#387Modified Human Four Helical Bundle Polypeptides and Their Uses
#388Modified human four helical bundle polypeptides and their uses
#389Modified Human Four Helical Bundle Polypeptides and Their Uses
#390Methods for measuring the metabolism of neurally dervied biomolecules in vivo
#391Modified Human Interferon Polypeptides and Their Uses
#392Modified Human Interferon Polypeptides and Their Uses
#393Modified Human Growth Hormone Polypeptides and Their Uses
#394Modified human interferon polypeptides with at least one non-naturally encoded amino acid and their uses
#395Modified Human Growth Hormone Polypeptides and Their Uses
#396Modified Human Growth Hormone Polypeptides and Their Uses
#397METHODS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE SECRETION OF HMGB1
#398Modified human four helical bundle polypeptides and their uses
#399Method for Identifying Histone Deacetylase Inhibitors
#400PYRUVATE-KINASE AS A NOVEL TARGET MOLECULE
#401Test System for the Discovery of Substances for the Promotion of Neuraxonal Growth
#402Lateral flow methods and devices for detection of nucleic acid binding proteins
#403Screening Methods and Transgenic Animals for the Treatment of Beta-Globin Related Disease and Conditions
#404Method for identifying compounds that modulate RXR associated processes with IgE production
#405Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
#406PROCESSES FOR RECEPTOR SCREENING
#407Adiponectin expression-inducing agents and uses thereof
#408Methods for diagnosing and for monitoring the treatment of recurrent spontaneous abortion
#409Detection of histone modification in cell-free nucleosomes
#410HPRP4s modifiers of the p53 pathway and methods of use
#411Multiplex in situ immunohistochemical analysis
#412Interaction inhibitors, method of detecting interaction inhibitor and kit detecting interaction inhibitor
#413Use of histones for the early diagnosis and/or preventive therapy of virally-infected living cells and a biochip for carrying out said diagnosis
#414Method for diagnosis of heart failure
#415Modulation of hnRNP H and treatment of DM1
#416Benzimidazole derivatives: preparation and pharmaceutical applications
#417Neuregulin protein regulation of synaptic proteins
#418Immunotherapeutic method of treating neoplastic conditions
#419Ligands for orphan nuclear hormone receptor steroidogenic factor-1 (SF-1)
#420Method for quantitative analysis for prolyl hydroxylase activity using fluorescence polarization
#421Lateral flow methods and devices for detection of nucleic acid binding proteins
#422Methods and compositions for the detection of cervical disease
#423ANALYSIS OF TISSUE SAMPLES SURROUNDING MALIGNANCIES
#424Transcription factor target gene discovery
#425Antibodies against biotinylated histones and related proteins and assays related thereto
#426Methods and compositions for the detection of cervical disease
#427Substrate for Rpn11 enzymatic activity
#428Monoclonal antibodies to RNA binding protein GW182
#429Peroxisome proliferator-activated receptor
#430Sphks as modifiers of the p53 pathway and methods of use
#431Modulation of the synthesis of insulin
#432Method for screening compounds for those that modulate transducers of regulated CREB activity
#433Biocidal molecules, macromolecular targets and methods of production and use
#434Antagonists of HMG1 for treating inflammatory conditions
#435Novel therapies and methods of screening for therapeutic compounds
#436Rhesus monkey Nur77
#437Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
#438Methods of diagnosing sepsis by measuring HMG1
#439Methods and compositions for identifying anti-HCV agents
#440Alzheimer's related proteins and methods of use
#441Method of screening drug
#442Compounds acting at the centrosome
#443Modulating nuclear receptor coactivator binding
#444Nuclear receptor err y 3
#445Monoclonal antibody specific for PPAR gamma, hydridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same
#446WDR11 protein assay
#447Enabling tools to identify ligands for hormone nuclear receptors
#448Nuclear matrix protein fluid assay
#449Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein
#450TRIM 5 related protein as a biomarker of neurodegenerative disease
#451Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof
#452Modifications of histone proteins as indicators of cell proliferation and differentiation
#453Acetylated protein
#454Methods to diagnose and treat lung cancer
#455Use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity
#456T-bet antibodies
#457Method of identifying active chromatin domains
#458Use of nuclear hormone receptors
#459Post-translational modifications of proteins as regulatory switches
#460Tr4/tr2 response elements
#461Use of Smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney
#462Screening method
#463Position dependent recognition of GNN nucleotide triplets by zinc fingers
#464Novel pathways in the etiology of cancer
#465Position dependent recognition of GNN nucleotide triplets by zinc fingers
#466Methods for controlling proliferation of cells
#467Class II human histone deacetylases, and uses related thereto
#468Method for diagnosing arrhythmogenic right ventricular dysplasia
#469Method for increasing synaptic growth or plasticity
#470RIP140 regulation of glucose transport
#471Methods and compositions for the detection of cervical disease
#472Method for diagnosing or predicting susceptibility to psychiatric disorders
#473Chromatin remodeling protein as a marker expressed by stromal progenitor cells
#474Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (DLE)
#475Compositions and Methods for Evaluating and Designing Nuclear Receptor Ligands that Modulate Co-Regulator Affinity
#476Modified human interferon polypeptides and their uses
#477Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses
#478Soluble TCR molecules and methods of use
#479Method of screening a chemical for binding to a proline-rich nuclear receptor co-regulatory protein/nuclear receptor complex
#480Plus end-directed microtubule motor required for chromosome congression
#481Method for screening a substance which can suppress degradation of a nuclear receptor or a substance which can promote degradation of a nuclear receptor
#482Method of identifying ligands for nuclear receptors
#483Human growth hormone modified at position 35
#484Mustang, a gene and nuclear protein
#485Methods of screening for compounds that modulate hormone receptor activity
#486Tagging and recovery of elements associated with target molecules
#487Assay and treatment
#488Compositions and methods for treating cells having double minute DNA
#489Histone h3methyltransferase polypeptide
#490Compositions, methods and assays related to secretase cleavage specificity
#491Nucleic acid mapping using linear analysis
#492Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car
#493Non-invasive diagnostic test utilizing histone modification markers
#494Asparagine hydroxylation of the CAD domain of a HIF protein
#495Nuclear matrix protein fluid assay
#496Inhibiting cellular proliferation by expressing yin yang-1
#497Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease